Sickle Cell Disease and Cardiovascular Damage: Understanding the connection and straregies for prevention

Authors

DOI:

https://doi.org/10.56294/hl2024.667

Keywords:

Drepanocytosis, Sickle cell disease, Cardiovascular damage, Anemia

Abstract

Introduction: Cardiovascular alterations contribute to the morbidity of adult patients with sickle cell disease, as a clinical expression of chronic organ damage. Sickle cell disease is a generic term assigned to a group of genetic disorders characterizedby a predominance of hemoglobin S(HBS) and clinically expressed in homozygous or doublé heterozygous patients. Development: Alterations in cardiac morphology and function were identified from the earliest cases of sickle cell disease. The prevalence of cardiac involvement in adult patients with sickle cell disease has been estimated to be as high as 82%. Conclusions: Patients with sickle cell disease exhibit a high prevalence of cardiovascular alterations, including the need for regular cardiovascular monitoring in this population.

References

1- Concepción-Fernández Y, Agramonte-Llanes O, Quintero-Sierra Y. El dolor en la drepanocitosis. Revista Cubana de Hematología, Inmunología y Hemoterapia [Internet]. 2020 [citado 1 Jun 2023]; 36 (2) Disponible en: https://revhematologia.sld.cu/index.php/hih/article/view/1089

2- Soler Noda Gilberto, Escalona Muñoz Lilia Zenaida, Peña Leyva Kirenia. Nuevos aspectos moleculares y fisiopatológicos de la anemia drepanocítica. Rev cubana med [Internet]. 2021 Mar [citado 2023 Jun 01] ; 60( 1 ): e505. Disponible en:http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S003475232021000100012&lng=es.Epub 25-Feb-2021

3- Svarch E, Machín-García S. Epidemiología de la drepanocitosis en países de América Latina y del Caribe. Revista Cubana de Hematología, Inmunología y Hemoterapia [Internet]. 2020 [citado 1 Jun 2023]; 36 (2) Disponible en: https://revhematologia.sld.cu/index.php/hih/article/view/1112

4- Fernández-Aguila J. Anemia falciforme: a 110 años de la descripción del primer caso. Revista Cubana de Hematología, Inmunología y Hemoterapia[Internet]. 2020 [citado 1 Jun 2023]; 36 (2) Disponible en: https://revhematologia.sld.cu/index.php/hih/article/view/1200

5- liana Flor. Famosos con Anemia Falciforme/Drepanocitosis. [Internet]. 2021 [citado 1 Jun 2023]; 36 (2) Disponible en:https://www.diseasemaps.org/es/sickle-cell-anemia/topquestions/famosos/

6- Mangla A, Ehsan M, Agarwal N. Sickle Cell Anemia. StatPearls [Internet]. 2023 [citado 20/02/2024]; Disponible en: https://www.ncbi.nlm.nih.gov/books/NBK482164/

7- Marcheco-Teruel B, Suárez Besil B, Gómez Martínez M, Collazo Mesa T, Pérez Rodríguez J, García Heredia M, et al. Impacto del programa de prevención de anemia por hematíes falciformes en Cuba: 1982-2016. Anales de la Academia de Ciencias de Cuba [Internet]. 2018 [citado 16/02/2024]; 8 (1) Disponible en: https://revistaccuba.sld.cu/index.php/revacc/article/view/440

8- Argemi J, Ventura Cots M, Rachakonda V, Bataller R. Alcoholic-related liver disease: pathogenesis, management and future therapeutic developments. Rev Esp Enferm Dig [Internet]. 2020;112(11):86978. [access: 20/12/2023]. Available from: https://www.ncbi.nlm.nih.gov/pubmed/33054302

9- Chotivanich K, Udomsangpetch R, Pattanapanyasat K, Chierakul W, Simpson J, Looareesuwan S, et al. Hemoglobin E: a balanced polymorphism protective against high parasitemias and thus severe P. falciparum malaria. Blood. 2002[acceso: 15/05/2020];100(4):1172-6. Disponible en: http://www.bloodjournal.org/content/100/4/1172

10- Erramouspe B, Eandi Eberle SJ. Conventional techniques applied to the diagnosis of hemoglobinopathies. Acta bioquím clín latinoam. 2017[acceso: 15/05/2020];51(3):325-32. Disponible en: http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S032529572017000300007&lng=es

11- ruz VH, Rosales RS, Lores GM, Roque C, Rodríguez LY. Perfil lipídico y estado redox asociados al estado vaso-oclusivo en la anemia drepanocítica. Rev Cubana Inv Biomed. 2022[citado 16/01/2023]; 42(1):e2449.Disponible en: https://revibiomedica.sld.cu/index.php/ibi/article/view/2449

12- Rojas-Jiménez Sara, Lopera-Valle Johan, Yabur-Espítia Mirna. Complicaciones cardiopulmonares en anemia de células falciformes. Arch. Cardiol. Méx. [revista en la Internet]. 2013 Dic [citado 2017 Sep 15]; 83(4): 289-294. Disponible en: http://www.scielo

13- Chou ST, Alsawas M, Fasano RM, et al. American Society of Hematology 2020 guidelines for sickle cell disease: transfusion support. Blood Adv. 2020;4(2):327-55. DOI: 10.1182/ bloodadvances.2019001143

14- Elshinawy M, Al Marhoobi N, Al Abri R, et al. Preoperative transfusion versus no transfusion policy in sickle cell disease patients: a randomized trial. Transfusion. 2020;60 Suppl 1:S22-S7. DOI: 10.1111/trf.15684

15- Machín García Sergio, Álvarez Molina Idalsys, Svarch Eva, Menéndez Veitía Andrea, Hernández Padrón Carlos, Sosa Palacios Oramis. Morbilidad y mortalidad de la anemia drepanocítica: estudio observacional de 36 años. Rev

Cubana Hematol Inmunol Hemoter [Internet]. 2015 Sep [citado 2017 Sep 15] ; 31( 3 ): 265-276. Disponible en: http://scielo.sld.

Downloads

Published

2024-12-30

How to Cite

1.
García Salgado AGS, Agramonte Llanes OM, Gámez Pérez A. Sickle Cell Disease and Cardiovascular Damage: Understanding the connection and straregies for prevention. Health Leadership and Quality of Life [Internet]. 2024 Dec. 30 [cited 2025 Aug. 24];3:.667. Available from: https://hl.ageditor.ar/index.php/hl/article/view/667